Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares semaglutide to liraglutide in adults with type 2 diabetes; results were completed and posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)
  • semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2019-08-28